Specifically, we assessed abdominal obesity using waist-hip-ratio adjusted for body mass index (WHRadjBMI) as its well-established proxy28,29, body mass index (BMI), CRP and metabolic dysfunction-associated steatotic liver disease (MASLD) in the UK Biobank (UKB)30,31. This evidence concerns the gene CRP and Abdominal obesity.